Skip to main content

Research Repository

Advanced Search

Genetic polymorphisms of the endocannabinoid system in obesity and diabetes

Doris, Joseph M.; Millar, Sophie A.; Idris, Iskandar; O'Sullivan, Saoirse E.

Genetic polymorphisms of the endocannabinoid system in obesity and diabetes Thumbnail


Authors

Joseph M. Doris

Sophie A. Millar

ISKANDAR IDRIS Iskandar.Idris@nottingham.ac.uk
Professor of Diabetes and Metabolic Medicine

Saoirse E. O'Sullivan



Abstract

The endocannabinoid system (ECS) is involved in many physiological processes including fertility, pain and energy regulation. The aim of this systematic review was to examine the contribution of single nucleotide polymorphisms (SNPs) of the ECS to adiposity and glucose metabolism. Database searches identified 734 articles, of which 65 were included; these covered 70 SNPs in genes coding for cannabinoid receptors 1 and 2 (CB1, CB2), fatty acid amide hydrolase (FAAH) and N‐acyl phosphatidylethanolamine phospholipase D (NAPE‐PLD). No studies included SNPs relating to monoacylglycerol lipase or diacylglycerol lipase. The CB1 receptor SNP rs1049353 showed 17 associations with lower body mass index (BMI) and fat mass (five studies). It also showed three associations with lower insulin levels (one study). Conversely, the CB1 receptor SNP rs806368 was associated with increased BMI and waist circumference (two studies). The FAAH SNP rs324420 was associated with increased obesity (three studies). A haplotype of NAPE‐PLD was associated with decreased BMI (one study). A total of 60 SNPs showed no association with any measured outcome. This review suggests a complex but important role of ECS SNPs in energy and glucose metabolism.

Citation

Doris, J. M., Millar, S. A., Idris, I., & O'Sullivan, S. E. (2019). Genetic polymorphisms of the endocannabinoid system in obesity and diabetes. Diabetes, Obesity and Metabolism, 21(2), 382-387. https://doi.org/10.1111/dom.13504

Journal Article Type Article
Acceptance Date Aug 10, 2018
Online Publication Date Aug 21, 2018
Publication Date Feb 1, 2019
Deposit Date Sep 24, 2018
Publicly Available Date Aug 22, 2019
Journal Diabetes, Obesity and Metabolism
Print ISSN 1462-8902
Electronic ISSN 1463-1326
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 21
Issue 2
Pages 382-387
DOI https://doi.org/10.1111/dom.13504
Keywords Polymorphisms; Endocannabinoid; Diabetes; Obesity; Cannabinoid
Public URL https://nottingham-repository.worktribe.com/output/1128291
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13504
Additional Information This is the peer reviewed version of the following article: Doris JM, Millar SA, Idris I, O'Sullivan SE. Genetic polymorphisms of the endocannabinoid system in obesity and diabetes. Diabetes Obes Metab. 2018;1–6. https://doi.org/10.1111/dom.13504, which has been published in final form at https://onlinelibrary.wiley.com/action/showCitFormats?doi=10.1111%2Fdom.13504. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Contract Date Sep 24, 2018

Files





You might also like



Downloadable Citations